Modulo Bio
PrivateLast Round
Strategic
Mar 19, 2025
Total Funding Raised
$19.15M
Company Overview
Modulo Bio is a biotechnology company that develops treatments for neurodegenerative disorders by reprogramming the brain's immune system.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Modulo Bio Comparables
Compare Modulo Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AcuraStem | 85% | |
| Monument Biosciences | 81% | |
| Muna Therapeutics | 79% |
Modulo Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Mar 19, 2025 | ||||
| Grant | Feb 7, 2025 | ||||
| Seed | Dec 5, 2024 | ||||
| Seed | Jun 1, 2023 |
Modulo Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The ALS Association | Grant |
| Refactor Capital | Seed |
| Builders VC | Seed |
| Cantos Ventures | Seed |
| Hawktail Management | Seed |
| Bioverge | Seed |
| Initialized Capital Management | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 19, 2025
$4.8M raised in early funding.
- Feb 7, 2025
$500K raised in a Grant round.
Modulo Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Modulo Bio's valuation, stock price, and market status.
Is Modulo Bio a public or private company?
Modulo Bio is a private company.
What is the current stock price of Modulo Bio?
Modulo Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Modulo Bio worth (valuation)?
Valuation information for Modulo Bio is not publicly available.
Can I buy Modulo Bio stock?
Modulo Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Modulo Bio's last funding round?
Modulo Bio's most recent funding round was Early Funding on March 19, 2025.
Who are the main investors in Modulo Bio?
Key investors in Modulo Bio include Alzheimer's Drug Discovery Foundation.
Will Modulo Bio IPO soon?
No public IPO plans have been announced for Modulo Bio.
How can I track Modulo Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Modulo Bio's secondary market activity and sign up for updates.